ZBIO
ZBIO
US98937L1052
Zenas BioPharma, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 10.000.000 5.000.000
100.0%
Cost of Revenue -- --
--
Gross Profit -- --
--
221.385.000 168.888.000
31.1%
Operating Income -211.385.000 -163.888.000
29.0%
Pretax Income -377.816.000 -156.559.000
141.3%
Net Income Common Stockholders -377.737.000 -156.988.000
140.6%
-- --
--
-- --
--
ende